Author: Ken Dropiewski

NorthStar Mapping System Now Commercially Available in the United States

Radiology Rhythm by 0 comments

MINNEAPOLIS–(BUSINESS WIRE)– #WeareiMR–Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar® Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings the field of interventional MR (iMR) to life. NorthStar provides physicians with an entirely ne

Continue Reading →

Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care

Financial by 0 comments

SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic commercialization collaboration with Johnson & Johnson to expand access to Viz.ai’s Subdural Hemorrhage software solution across hospitals in the United States for automated detection, labeling and quantification of subdural collections. By integrating the Viz Subdural solution into its neurovascular offerings, the company aims to support hospital

Continue Reading →

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Rhythm by 0 comments

Clinical illustration of the Philips Bridge Plus balloon in use

Clinical illustration of the Philips Bridge Plus balloon in use

The Philips Bridge Plus Balloon, uninflated prior to use

The Philips Bridge Plus Balloon, uninflated prior to use

The inflated Philips Bridge Plus Balloon

The inflated Philips Bridge Plus Balloon

April 23, 2026   Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in

Continue Reading →

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

Coronary/Structural Heart by 0 comments

SAN DIEGO, April 23, 2026 /PRNewswire/ — Atrium Therapeutics, Inc. (Nasdaq: RNA) (the “Company”), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced today it has earned a $15 million development milestone payment from Bristol Myers…

Continue Reading →

New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction

Coronary/Structural Heart by 0 comments

New guidance reframes HFmrEF as a distinct, clinically meaningful condition requiring consistent recognition and management WASHINGTON, April 22, 2026 /PRNewswire/ — A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the…

Continue Reading →
1 2 3 4 5 6 … 1,329